Clinical Trial Details

Trial ID: L0795
Source ID: IRCT20180513039634N1
Associated Drug: Crocin
Title: Evaluation of the effect of Crocin on the serum levels of liver enzymes and Lipid Profile in patients with non-alcoholic fatty liver disease
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: non-alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: Intervention group: receiving one tablet containing 15 mg of Crocin (Samisaz Pharmaceutical Co.) daily with meal for 8 weaks. Intervention 2: Control group: receiving one tablet placebo (maltodextrin) daily with meal for 8 weaks.
Outcome Measures: ALT. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;AST. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;TC, TG, LDL, HDL. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometry.nan
Sponsor/Collaborators: Ahvaz University of Medical Sciences
Gender: All
Age: 18 yearsno limit
Phases: Phase 3
Enrollment: 60
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization, Blinding description: To maintain the double-blinded condition of the study design, labeled stud
Start Date: 13/06/2018
Completion Date: --
Results First Posted: --
Last Update Posted: 16 July 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/31115